Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.

Angiogenesis and lymphangiogenesis are involved in tumoral growth and metastatic spread. There is little information on angiogenesis and no available data on lymphangiogenesis in parathyroid glands (PTG). Using immunohistochemistry for CD34, LYVE-1 (specific markers for vascular and lymphatic endoth...

ver descrição completa

Detalhes bibliográficos
Main Authors: Garcia de la Torre, N, Buley, I, Wass, J, Jackson, D, Turner, H
Formato: Journal article
Idioma:English
Publicado em: 2004
_version_ 1826304759768809472
author Garcia de la Torre, N
Buley, I
Wass, J
Jackson, D
Turner, H
author_facet Garcia de la Torre, N
Buley, I
Wass, J
Jackson, D
Turner, H
author_sort Garcia de la Torre, N
collection OXFORD
description Angiogenesis and lymphangiogenesis are involved in tumoral growth and metastatic spread. There is little information on angiogenesis and no available data on lymphangiogenesis in parathyroid glands (PTG). Using immunohistochemistry for CD34, LYVE-1 (specific markers for vascular and lymphatic endothelium, respectively), vascular endothelial growth factor (VEGF)-A, VEGF-C, and fibroblast growth factor (FGF)-2, this study analyzes microvascular density (MVD), lymphatic vascular density (LVD), and expression of angiogenic and lymphangiogenic growth factors in 13 normal PTG, 77 parathyroid adenomas (PTA), and 17 primary parathyroid hyperplasia (PPH). MVD was higher in PPH and PTA, compared with PTG (P < 0.001). There was no difference in VEGF-A expression among groups. In contrast, FGF-2 expression was higher in PPH, compared with PTA and PTG (P < 0.0001). FGF-2 scores and MVD were significantly correlated (r = 0.43). LVD did not differ among groups, and VEGF-C expression was unrelated to LVD. There was no relationship between MVD and tumor behavior (adenoma size, PTH, or calcium). In conclusion, this study shows increased angiogenesis in parathyroid proliferative lesions compared with normal glands and suggests that FGF-2 is proangiogenic in parathyroid tissue. In PTA, tumor behavior is not related to angiogenic phenotype. This is the first demonstration of lymphatic vessels in PTG, but the lack of correlation with VEGF-C expression suggests that VEGF-C is not the primary lymphangiogenic factor.
first_indexed 2024-03-07T06:22:39Z
format Journal article
id oxford-uuid:f333b021-e5df-4f6f-99c7-c79537f43f0e
institution University of Oxford
language English
last_indexed 2024-03-07T06:22:39Z
publishDate 2004
record_format dspace
spelling oxford-uuid:f333b021-e5df-4f6f-99c7-c79537f43f0e2022-03-27T12:10:20ZAngiogenesis and lymphangiogenesis in parathyroid proliferative lesions.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f333b021-e5df-4f6f-99c7-c79537f43f0eEnglishSymplectic Elements at Oxford2004Garcia de la Torre, NBuley, IWass, JJackson, DTurner, HAngiogenesis and lymphangiogenesis are involved in tumoral growth and metastatic spread. There is little information on angiogenesis and no available data on lymphangiogenesis in parathyroid glands (PTG). Using immunohistochemistry for CD34, LYVE-1 (specific markers for vascular and lymphatic endothelium, respectively), vascular endothelial growth factor (VEGF)-A, VEGF-C, and fibroblast growth factor (FGF)-2, this study analyzes microvascular density (MVD), lymphatic vascular density (LVD), and expression of angiogenic and lymphangiogenic growth factors in 13 normal PTG, 77 parathyroid adenomas (PTA), and 17 primary parathyroid hyperplasia (PPH). MVD was higher in PPH and PTA, compared with PTG (P < 0.001). There was no difference in VEGF-A expression among groups. In contrast, FGF-2 expression was higher in PPH, compared with PTA and PTG (P < 0.0001). FGF-2 scores and MVD were significantly correlated (r = 0.43). LVD did not differ among groups, and VEGF-C expression was unrelated to LVD. There was no relationship between MVD and tumor behavior (adenoma size, PTH, or calcium). In conclusion, this study shows increased angiogenesis in parathyroid proliferative lesions compared with normal glands and suggests that FGF-2 is proangiogenic in parathyroid tissue. In PTA, tumor behavior is not related to angiogenic phenotype. This is the first demonstration of lymphatic vessels in PTG, but the lack of correlation with VEGF-C expression suggests that VEGF-C is not the primary lymphangiogenic factor.
spellingShingle Garcia de la Torre, N
Buley, I
Wass, J
Jackson, D
Turner, H
Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
title Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
title_full Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
title_fullStr Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
title_full_unstemmed Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
title_short Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
title_sort angiogenesis and lymphangiogenesis in parathyroid proliferative lesions
work_keys_str_mv AT garciadelatorren angiogenesisandlymphangiogenesisinparathyroidproliferativelesions
AT buleyi angiogenesisandlymphangiogenesisinparathyroidproliferativelesions
AT wassj angiogenesisandlymphangiogenesisinparathyroidproliferativelesions
AT jacksond angiogenesisandlymphangiogenesisinparathyroidproliferativelesions
AT turnerh angiogenesisandlymphangiogenesisinparathyroidproliferativelesions